Page last updated: 2024-08-24

baicalin and Cognition Disorders

baicalin has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Gao, P; Li, J; Li, X; Liang, H; Tu, Y; Zhang, S; Zhao, M1
Cao, YG; Li, XL; Liu, ZQ; Ma, P; Ma, Y; Mao, XY; Qiao, YD; Zhou, HH1

Other Studies

2 other study(ies) available for baicalin and Cognition Disorders

ArticleYear
Baicalin attenuates alzheimer-like pathological changes and memory deficits induced by amyloid β1-42 protein.
    Metabolic brain disease, 2015, Volume: 30, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cognition Disorders; Cytokines; Flavonoids; Immunohistochemistry; Macrophage Activation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Neuroglia; Peptide Fragments

2015
Baicalin alleviates diabetes‑associated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brain‑derived neurotrophic factor and apoptosis.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Acetylcholinesterase; Animals; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Brain-Derived Neurotrophic Factor; Caspase 3; Choline O-Acetyltransferase; Cognition Disorders; Diabetes Mellitus, Experimental; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hippocampus; JNK Mitogen-Activated Protein Kinases; Male; Maze Learning; Memory; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Rats; Rats, Wistar; Streptozocin

2015